With Johnson & Johnson's acquisition of Orthotaxy, it joins a growing list of medtech players seeking to beef up their offerings in the surgical robotics market.
News & Features
Banyan Biomarkers is one of the first companies to bring a blood-based test to aid in the detection of traumatic brain injuries and concussions to the U.S. market.
The way FDA analyzes recalls and applies its list of root-cause possibilities needs a dose of transparency.
The company says its ImmunoPoC platform can determine in 15 minutes whether a patient has a bacterial or viral infection.
Becton Dickinson is suing competitor Cytek, claiming that the company stole information after hiring several former BD employees.
Edwards picks up a CE mark for the Centera valve in a move that could strengthen its position in the growing TAVR market.
The company has teamed up with the International Olympic Committee to bring precision medicine to the winter games.
Here's a look at the companies that broke into the ranks of the top 100 medical device and diagnostics companies last year.
Designed for extended wear, the adhesive firmly bonds to the wearer’s skin while remaining comfortable, 3M reports.
LivaNova said it will pay up to $250 million for TandemLife, a deal that will significantly bolster its cardiac surgery portfolio.
Pricing headwinds under the Medtronic agreement is expected to slow Mazor's growth in 2018, but longer-term prospects are promising.
FDA's recent approval of stroke detection software paves the way for Artificial Intelligence applications to thrive on the healthcare landscape.
The wearables company said it will acquire Twine Health, a health coaching platform aimed at lowering healthcare costs.